Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gene Therapy00:59

Gene Therapy

24.9K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
24.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
The Central Dogma01:20

The Central Dogma

19.3K
The central dogma explains the flow of genetic information from DNA nucleotides to the amino acid sequence of proteins.
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
19.3K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.7K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TKI-mediated inhibition of NLRP1 inflammasome restores erythropoiesis in DBA syndrome.

EMBO molecular medicine·2026
Same author

GMP-compliant manufacturing of allogeneic peripheral blood CAR-NK cells for the treatment of acute myeloid leukemia.

Cytotherapy·2025
Same author

Base edited skin equivalents with clinical potential for ex vivo correction of recessive dystrophic epidermolysis bullosa.

Molecular therapy : the journal of the American Society of Gene Therapy·2025
Same author

Lentiviral-mediated panErbB CAR-T cell therapy against head and neck squamous cell carcinomas for patients with Fanconi anemia.

Molecular therapy. Oncology·2025
Same author

A presumed mouse parvovirus with overlooked high toxicity for human primitive CD34<sup>+</sup> hematopoietic precursors <i>in vitro</i> and in bone marrow-humanized mice.

Microbiology spectrum·2025
Same author

A Novel Early Memory-Enriched Allogeneic NKG2D CAR-T Cell Therapy Based on CRISPR/Cas9 Technology for Solid Tumors.

Cancers·2025

Related Experiment Video

Updated: May 7, 2025

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells
11:16

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells

Published on: February 15, 2019

7.5K

All-in-one gene therapy alternative for DBAS.

Susana Navarro1, Paula Río1

  • 1Division of Hematopoietic Innovative Therapies, CIEMAT, Madrid, Spain; Instituto Nacional de Investigación Biomédica en Enfermedades Raras (CIBERER), Madrid, Spain; Advanced Therapies Unit, IIS-Fundación Jimenez Diaz (IIS-FJD, UAM), 28040 Madrid, Spain.

Cell Stem Cell
|January 3, 2025
PubMed
Summary

Diamond-Blackfan anemia is a rare bone marrow failure syndrome with many genetic causes. Preclinical findings suggest a universal lentiviral gene therapy approach may treat patients effectively, irrespective of their specific genetic variant.

More Related Videos

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
12:04

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on: March 10, 2023

3.4K
CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications
08:32

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

Published on: August 9, 2022

3.4K

Related Experiment Videos

Last Updated: May 7, 2025

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells
11:16

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells

Published on: February 15, 2019

7.5K
Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
12:04

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on: March 10, 2023

3.4K
CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications
08:32

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

Published on: August 9, 2022

3.4K

Area of Science:

  • Hematology
  • Genetics
  • Molecular Biology

Background:

  • Diamond-Blackfan anemia (DBA) is a rare inherited bone marrow failure syndrome.
  • DBA is a ribosomopathy characterized by significant genetic heterogeneity, with up to 24 identified genetic variants.
  • Current treatments for DBA are limited and often focus on managing symptoms rather than addressing the underlying genetic cause.

Purpose of the Study:

  • To evaluate a universal lentiviral gene therapy strategy for Diamond-Blackfan anemia.
  • To provide preclinical evidence supporting a gene therapy approach that is independent of the specific genetic mutation.
  • To explore a potential curative treatment for DBA patients with diverse genetic backgrounds.

Main Methods:

  • Preclinical studies were conducted to assess the efficacy of lentiviral gene therapy.
  • The study focused on developing a gene therapy vector capable of delivering functional genetic material to correct the defect in red blood cell production.
  • The approach aimed for broad applicability across different genetic variants of DBA.

Main Results:

  • Compelling preclinical evidence demonstrated the potential of the universal lentiviral gene therapy strategy.
  • The gene therapy approach showed promise in addressing the core defect in erythropoiesis characteristic of DBA.
  • Results support the feasibility of a one-size-fits-all gene therapy for DBA.

Conclusions:

  • A universal lentiviral gene therapy strategy shows significant promise for treating Diamond-Blackfan anemia.
  • This approach offers a potential therapeutic avenue for patients with various genetic mutations causing DBA.
  • Further development of this gene therapy could represent a breakthrough in managing this complex bone marrow failure syndrome.